Skip to main content
. 2017 Jul 31;8(49):86816–86827. doi: 10.18632/oncotarget.19735

Figure 2. Relative relationship forest plots of PFS and OS.

Figure 2

Note: PFS = Progression-free survival; OS = overall survival; 95% CI = 95% confidence interval; A = erlotinib + placebo regimen; B = erlotinib + tivantinib regimen; C = erlotinib + celecoxib regimen; E = erlotinib + sunitinib regimen; G = erlotinib + sorafenib regimen.